112 related articles for article (PubMed ID: 8881917)
1. Proliferating cell nuclear antigen expression in papillary thyroid carcinoma.
Ando H; Funahashi H; Ito M; Imai T; Takagi H
J Clin Pathol; 1996 Aug; 49(8):657-9. PubMed ID: 8881917
[TBL] [Abstract][Full Text] [Related]
2. Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer.
Basolo F; Pinchera A; Fugazzola L; Fontanini G; Elisei R; Romei C; Pacini F
Eur J Cancer; 1994; 30A(2):171-4. PubMed ID: 7908818
[TBL] [Abstract][Full Text] [Related]
3. Study of immunohistochemical expression of insulin-like growth factor I and proliferating cell nuclear antigen in thyroid gland papillary carcinoma and its metastasis.
Silva Filho GB; Maciel RM; Takahashi MH; Alberti VN; Castro IV; Saldiva PH; Durazzo MD; Ferraz AR
Head Neck; 1999 Dec; 21(8):723-7. PubMed ID: 10562685
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas.
Revesz T; Alsanjari N; Darling JL; Scaravilli F; Lane DP; Thomas DG
Neuropathol Appl Neurobiol; 1993 Apr; 19(2):152-8. PubMed ID: 8100356
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
Korkolopoulou P; Oates J; Crocker J; Edwards C
J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
[TBL] [Abstract][Full Text] [Related]
6. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 and proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma.
Cvejic D; Savin S; Petrovic I; Selemetjev S; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2005 Sep; 27(3):210-4. PubMed ID: 16244583
[TBL] [Abstract][Full Text] [Related]
9. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas.
Matias-Guiu X; Cuatrecasas M; Musulen E; Prat J
J Clin Pathol; 1994 Apr; 47(4):337-9. PubMed ID: 8027371
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma.
Hattori K; Uchida K; Akaza H; Koiso K; Nemoto R; Harada M
Br J Urol; 1995 Feb; 75(2):162-6. PubMed ID: 7850319
[TBL] [Abstract][Full Text] [Related]
13. Tumor proliferation-related markers in papillary thyroid carcinomas: correlation with histologic subtypes.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1993; 13(1):267-71. PubMed ID: 8097390
[TBL] [Abstract][Full Text] [Related]
14. No relationship between proliferative activity and the MACIS prognostic scoring system in papillary thyroid carcinoma.
Moreira Leite KR; de Araujo VC; Rezende Meirelles MI; Lopes Costa AD; Camara-Lopes LH
Head Neck; 1999 Oct; 21(7):602-5. PubMed ID: 10487946
[TBL] [Abstract][Full Text] [Related]
15. TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors.
Matsuse M; Yabuta T; Saenko V; Hirokawa M; Nishihara E; Suzuki K; Yamashita S; Miyauchi A; Mitsutake N
Sci Rep; 2017 Feb; 7():41752. PubMed ID: 28150740
[TBL] [Abstract][Full Text] [Related]
16. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
17. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
Xu YJ
Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma.
Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R
Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863
[TBL] [Abstract][Full Text] [Related]
19. Nuclear p53 immunoreactivity in papillary thyroid cancers is associated with two established indicators of poor prognosis.
Gerasimov G; Bronstein M; Troshina K; Alexandrova G; Dedov I; Jennings T; Kallakury BV; Izquierdo R; Boguniewicz A; Figge H
Exp Mol Pathol; 1995 Feb; 62(1):52-62. PubMed ID: 7556591
[TBL] [Abstract][Full Text] [Related]
20. Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder, and its relationship to prognosis.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ishimaru S; Hirata M; Kajiyama G
Scand J Clin Lab Invest; 1995 Aug; 55(5):377-82. PubMed ID: 8545595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
